Investment Banking & Brokerage

Jefferies (NYSE: JEF) Upgrades Parametric Technology (NASDAQ: PMTC) to Buy.

Pre-open movers US stock futures are higher this morning. Oil prices surged above $111 a barrel. Futures on the Dow Jones Industrial Average rose 43 points to 12,394.00 and S&P 500 index futures surged 5.50 points to 1,334.00. Futures on the Nasdaq 100 gained 6 points at 2,335.25. A Peek Into...

BJ's Wholesale Club (NYSE: BJ) Raised to conviction Buy at Goldman Sachs (NYSE: GS).

KBW has issued a report on Jefferies Group (NYSE: JEF). According to KBW, "Jefferies Group announced that it commenced a public offering of $500 million of its common stock." JEF is rated Outperform and closed at $24.71 a share yesterday.

Goldman Sachs (NYSE: GS) has acquired a 12% stake in China's Taikang Life Insurance Co Ltd worth more than $900 million. Analysts have projected that Goldman's ownership could fast-track Taikang's planned initial public offering next year. $124 billion in premium income was generated in China in...

Jefferies Group, Inc. (NYSE: JEF) announced today that it is commencing an underwritten public offering of $500 million of the Corporation's common stock. The offering is being underwritten by Jefferies & Company, Inc., the broker-dealer subsidiary of Jefferies Group, Inc.

Europe raised interest rates this morning by 25 basis points, as it looks to deal with rising inflation caused by surging oil prices. Portugal asked for a bailout yesterday, which could potentially affect Spanish banks like Santander (NYSE: STD), which hold Portuguese debt. President Barack Obama...

Goldman Sachs Group, Inc. (NYSE: GS) shares are moving straight up, up $1.67 to $163.56, a gain of 1.03%. Shares shot straight up this morning, and are worth eying, as financials continue to move higher.

Biogen Idec (NASDAQ: BIIB) shares have been strong YTD and many investors are questioning the risk / reward profile ahead of next week's AAN meeting. There should be a lot of buzz on the oral agents in multiple sclerosis (MS) at AAN, but what is also a near-term event is the pending approval of the...

Biogen Idec (NASDAQ: BIIB) shares have been strong YTD and many investors are questioning the risk / reward profile ahead of next week's AAN meeting. There should be a lot of buzz on the oral agents in multiple sclerosis (MS) at AAN, but what is also a near-term event is the pending approval of the...

Jefferies Group, Inc. (NYSE: JEF) announced today that it has entered into a definitive agreement to acquire Prudential Bache's Global Commodities Group from Prudential Financial, Inc. for a purchase price equal to tangible book value, or approximately $430 million.

CNBC Fast Money's Guy Adami said on Fast Money Pops & Drops that Panera Bread Company (NASDAQ: PNRA) could drop additional $5. He added that the valuation looks a little bit stretched. Panera Bread Company (PNRA) fell 3.72% today, and closed at $123.90. Tim Seymour explained that Nokia...

The market continued its sideways move yesterday and banged-up against 1335 resistance for most of the afternoon. Over the past three sessions the market has been stuck in a four point range and trading on miniscule volume.  The minimal participation and movement is...

KBW is out with its report today on Morgan Stanley (NYSE: MS), lowering EPS estimates. In a note to clients, KBW writes, "We are lowering our first quarter estimate to $0.08 from $0.45 per share and our full year 2011 estimates to $1.95 from $2.47. In addition, we are lowering our 2012 estimates...

On CNBC's Mad Money Lightning Round OT, Jim Cramer said that Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) reminds him on Cephalon, Inc. (NASDAQ: CEPH), and Genzyme Corporation (NASDAQ: GENZ). It is the company that is doing a lot of good, and it is what this market wants. Cramer would stick with...